CAMP4 to Participate in Upcoming Investor Conferences

▤ Summary

CAMP4 Therapeutics announced that it will participate in upcoming investor conferences. The company operates in the biopharmaceutical sector and focuses on regulatory RNA-targeting therapeutics for genetic diseases. The notice provides webcast and replay access details through CAMP4’s investor relations page. It also includes a brief overview of CAMP4’s RAP Platform and its approach to upregulating gene expression.

▦ Linked Companies